The approval of Onstryv marks the beginning of hope for an estimated 100,000 Canadians afflicted with Parkinson’s Disease. Valeo Pharma Inc., together with Zambon S.p.A, has declared the official …
Drugstore giant Walgreens has reportedly entered into a seven-year agreement with Microsoft Corporation for the research and development of new methods aimed at augmenting the delivery of healthcare solutions …
Suzhou Alphamab Co. and Ascletis Pharma Inc. together announced that Alphamab and the subsidiary of Ascletis have signed an exclusive licensing agreement and entered into a strategic collaboration for …
The National Institute for Health and Care Excellence (NICE), the public body under the Department of Health in England, has reportedly rejected Novartis’ migraine treatment drug Aimovig (erenumab). As …
The move will advance Glenmark’s vision of helping Ryaltris gain access to several key markets worldwide. India’s drug major, Glenmark Pharmaceuticals Ltd. has recently announced that its Swiss subsidiary …
The collaboration will be funded by Sanofi and the research would be reportedly conducted at AbSci. As per the agreement, AbSci will apply SoluProTM – the company’s breakthrough E. …
Lupin Limited has reportedly received the European Commission’s approval for its specialty drug NaMuscla used in the treatment of a rare neuromuscular disorder. As per trusted sources, Lupin is …
QIAGEN N.V., has recently announced that it has entered into a definitive agreement with N-of-One, Inc., the privately-held American molecular decision support company, which is renowned for innovating clinical …
L’Oréal is committed to investing in technology and the latest wearable tech can be used by dermatologists to access patients’ skin conditions and create skin health plans. L’Oréal, the …
A new breathalyzer test that is most likely to revolutionize the diagnosis of cancer will reportedly undergo clinical trials in Britain. As per credible sources, the breath test involves …
